Natural Killer Cells Therapies Report 2017: Competitive Landscape, Technology and Pipeline Analysis - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Natural Killer Cells Therapies - Competitive Landscape, Technology and Pipeline Analysis - 2017" drug pipelines to their offering.

Natural Killer Cells Therapies - Competitive Landscape, Technology and Pipeline Analysis - 2017, emphasizes on the currently active NK cell therapy products and NK cell augmenters in research and development.

The report covers 20+ companies, which are active in this field with 40+ products and many different technologies.

This report covers NK cell based therapies and drugs that augment (enhance or activate) the NK cells.

The report provides in-depth analysis on the Natural Killer Cell based therapies profiles along with the augmenting therapies covering their pre-clinical and clinical studies, collaborations details and deal values, technologies and targeted antigens.

The report provides the NK Cell based therapies licensing opportunities, acquisitions, market drivers and barriers followed by SWOT Analysis.

Report Highlights:

- NK cell Therapy Pipeline scenario which includes NK cell therapies and NK cell augmenting therapies

- Collaborations & partnering deals

- Current Prominent Research Areas and Key Players

- Pipeline product profiles NK Cell therapy Technologies and NK cell Augmenting Therapies

- Licensing opportunities

- Market Drivers and Barriers

Scope:

- Overview of the global NK cell therapy and NK cell augmenting therapies pipeline scenario, products and associated companies information

- Coverage of global NK cell therapies and drugs that enhance the activity of NK under development

- Competitive landscape of products for key players and related indications

- Coverage of licensors, collaborators and development partners, deal terms and deal values estimation

- Pipeline analysis across different phases, emerging trends and comparative analysis of pipeline products with detailed clinical profiles, mechanism of action, route of administration and molecule type, along with product development activities

- Highlights of licensing & collaboration opportunities and funding details

- Highlights of latest NK cell therapy technologies and NK cell augmenting therapies and innovative companies

- Key topics covered include strategic competitor assessment, barriers and drivers in the market along with SWOT analysis

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/fdvgbt/natural_killer

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Oncology Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Oncology Drugs